Private
8 months ago
31 Views

METiS Therapeutics

AI Business
Cambridge, Massachusetts, USA
funded over $100 million

Category

AI Business
Healthcare

METiS Therapeutics, founded in 2020 and headquartered in Cambridge, Massachusetts, is a biotechnology company that leverages artificial intelligence (AI), machine learning (ML), and molecular dynamics (MD) to revolutionize drug discovery and delivery. The company focuses on developing novel therapeutics across small molecules, biologics, and advanced nucleic acids, aiming to enhance the efficiency and precision of treatment delivery to various organ systems.

In December 2021, METiS announced an $86 million Series A financing round. Notable investors include 5Y Capital, Free Fund, L2 Capital, CMB International, XtalPi, and Source Code Capital.

METiS distinguishes itself by integrating AI and high-throughput in vivo screening to discover unique lipid nanoparticles (LNPs) capable of targeting multiple organ systems. This approach addresses challenges in drug delivery by improving the precision and efficacy of therapeutics, thereby enhancing patient outcomes.

In the AI landscape, METiS operates within the category of AI-driven drug discovery and delivery, applying advanced computational techniques to innovate and optimize pharmaceutical development processes.

For more information, please visit metistx.com.

 

 

To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.

Write a Review

Post as Guest
Your opinion matters
Minimum characters: 10
startupzone
Member since: 10 months
User is offline
See all ads
Add to favorites
Add to compare
Report abuse
© 2024 StartupZone.com. All rights reserved.